🔎 Trials Near Me

Hjem › Ulcerøs colitis › Texas › Dallas

Ulcerøs colitis kliniske forsøg i Dallas, TX

8 studier for Ulcerøs colitis søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis

RekruttererFase 3
  • University of Texas - Southwestern Medical Center /ID# 271835, Dallas
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07071519

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RekruttererFase 1
  • UT Southwestern Simmons Cancer Center - RedBird, Dallas
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RekruttererFase 2
  • GI Alliance - Dallas - Gaston Avenue, Dallas
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RekruttererFase 4
  • GI Alliance - Digestive Health Associates of Texas, Dallas
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekrutterer
  • University of Texas Southwestern, Dallas
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT05230173

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Dallas
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Ulcerøs colitis forsøg i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.